[go: up one dir, main page]

MX2009005838A - Uso de carrageninas para el tratamiento de infecciones por rinovirus. - Google Patents

Uso de carrageninas para el tratamiento de infecciones por rinovirus.

Info

Publication number
MX2009005838A
MX2009005838A MX2009005838A MX2009005838A MX2009005838A MX 2009005838 A MX2009005838 A MX 2009005838A MX 2009005838 A MX2009005838 A MX 2009005838A MX 2009005838 A MX2009005838 A MX 2009005838A MX 2009005838 A MX2009005838 A MX 2009005838A
Authority
MX
Mexico
Prior art keywords
antiviral composition
lambdacarrageenan
iota
kappa
prophylaxis
Prior art date
Application number
MX2009005838A
Other languages
English (en)
Inventor
Andreas Grassauer
Eva Prieschl-Grassauer
Christiane Meier
Alexander Pretsch
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39383268&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009005838(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP06450176A external-priority patent/EP1930015A1/en
Priority claimed from US11/567,078 external-priority patent/US20080131454A1/en
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Publication of MX2009005838A publication Critical patent/MX2009005838A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Paper (AREA)

Abstract

La presente invención prevé el uso de iota-, kappa o lambda carragenina o mezclas de lo mismo para la elaboración de una composición farmacéutica antiviral para la profilaxis o tratamiento contra infección por rinovirus.
MX2009005838A 2006-12-05 2007-12-04 Uso de carrageninas para el tratamiento de infecciones por rinovirus. MX2009005838A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06450176A EP1930015A1 (en) 2006-12-05 2006-12-05 Use of carrageenan for treating rhinovirus infections
US11/567,078 US20080131454A1 (en) 2006-12-05 2006-12-05 Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
PCT/EP2007/010512 WO2008067982A2 (en) 2006-12-05 2007-12-04 Use of carrageenan for treating rhinovirus infections

Publications (1)

Publication Number Publication Date
MX2009005838A true MX2009005838A (es) 2009-06-16

Family

ID=39383268

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005838A MX2009005838A (es) 2006-12-05 2007-12-04 Uso de carrageninas para el tratamiento de infecciones por rinovirus.

Country Status (23)

Country Link
EP (1) EP2101792B1 (es)
JP (1) JP5470047B2 (es)
KR (1) KR101437708B1 (es)
CN (1) CN101678040B (es)
AT (1) ATE462438T1 (es)
AU (1) AU2007327934B2 (es)
BR (1) BRPI0720054A2 (es)
CA (1) CA2671317C (es)
CY (1) CY1110658T1 (es)
DE (1) DE602007005697D1 (es)
DK (1) DK2101792T3 (es)
EA (1) EA015930B1 (es)
ES (1) ES2343701T3 (es)
IL (1) IL198810A (es)
MA (1) MA31145B1 (es)
MX (1) MX2009005838A (es)
NO (1) NO342681B1 (es)
NZ (1) NZ577063A (es)
PL (1) PL2101792T3 (es)
PT (1) PT2101792E (es)
SI (1) SI2101792T1 (es)
TN (1) TN2009000211A1 (es)
WO (1) WO2008067982A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2303287T1 (sl) * 2008-07-01 2014-04-30 Marinomed Biotechnologie Gmbh Antialergični morski biopolimeri
JP5702526B2 (ja) * 2009-04-30 2015-04-15 Ｅｓファイバービジョンズ株式会社 抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
SG181421A1 (en) 2009-12-22 2012-07-30 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
JP5900030B2 (ja) 2011-03-08 2016-04-06 凸版印刷株式会社 防湿容器
RS58731B1 (sr) * 2014-01-22 2019-06-28 Visufarma B V Kompozicija koja sadrži jota-karagenan protiv virusnog konjuktivitisa
MX372625B (es) 2015-07-14 2020-05-12 Marinomed Biotech Ag Composicion para desobstruir la nariz congestionada que tiene actividad antiviral
UA118192C2 (uk) * 2015-10-22 2018-12-10 Юрій Захарович Толчеєв Противірусна фармацевтична композиція
KR102316819B1 (ko) * 2018-04-20 2021-10-25 한미약품 주식회사 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
KR101995376B1 (ko) * 2018-08-20 2019-07-02 한미약품 주식회사 카라기난을 유효성분으로 포함하는 항-바이러스 조성물
GB2579600B (en) 2018-12-05 2023-07-05 Byotrol Plc Anti-viral composition
CN111437270A (zh) * 2020-04-24 2020-07-24 瑞希(重庆)生物科技有限公司 一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法
JP2023539940A (ja) 2020-09-08 2023-09-20 アルタミラ メディカ， アーゲー 感染を防止するための組成物
KR102720037B1 (ko) * 2021-12-21 2024-10-22 (주)메디코어 비강 세정제 조성물 및 그 제조방법
WO2025067689A1 (en) 2023-09-26 2025-04-03 Metriopharm Ag 5-amino-2,3-dihydro-1,4-phthalazinedione for the treatment of infections with an rna virus
WO2025114567A1 (en) * 2023-11-30 2025-06-05 Université De Strasbourg Biomaterial with simultaneous antibacterial and antiviral properties

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0112818A (pt) 2000-07-28 2004-10-19 Immupharm Aps Processo de tratamento de sintomas do resfriado comum, rinite alérgica e infecções relacionadas com o trato respiratório
US6953483B2 (en) * 2002-03-05 2005-10-11 Litke Kenneth S Aloe vera processed leather and leather gloves, garments, shoes and sandals made from aloe vera processed leather and a process for making aloe vera processed leather
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
CN1194981C (zh) * 2002-07-22 2005-03-30 青岛海洋大学 卡拉胶低聚糖的制备方法
CN100435805C (zh) * 2003-05-26 2008-11-26 福州大学 多糖硫酸酯作为制备抗流感病毒药物的应用
WO2005004882A1 (en) * 2003-07-09 2005-01-20 Monash University Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
EP1718315A4 (en) * 2004-02-06 2008-08-13 Univ Monash HIGH DOSE USE OF SULFATED POLYSACCHARIDES IN SHORT INTERVALS FOR THE TREATMENT OF INFECTIONS
DE202005014019U1 (de) * 2005-09-05 2005-11-24 G. Pohl-Boskamp Gmbh & Co. Kg Zubereitung zum Ersatz von Speichelflüssigkeit und zur Pflege bei Trockenheit der Mund- und Rachenschleimhäute
ITRM20060115A1 (it) * 2006-03-06 2006-06-05 Paolo Ottier Guanto costituito da tre strati sovrapposti di poliuretano di cui due a tenuta stagna contenenti olio lubrificante per la parpazione del seno femminile
DE102006031812A1 (de) 2006-07-07 2008-01-17 Leoni Ag Sensorsystem und Sensorelement

Also Published As

Publication number Publication date
NO342681B1 (no) 2018-07-02
ATE462438T1 (de) 2010-04-15
JP2010512307A (ja) 2010-04-22
CA2671317A1 (en) 2008-06-12
TN2009000211A1 (en) 2010-10-18
IL198810A (en) 2013-03-24
CN101678040B (zh) 2012-10-03
IL198810A0 (en) 2010-02-17
SI2101792T1 (sl) 2010-08-31
ES2343701T3 (es) 2010-08-06
WO2008067982A2 (en) 2008-06-12
NO20091955L (no) 2009-09-04
NZ577063A (en) 2011-05-27
EA200970529A1 (ru) 2009-12-30
KR20090096598A (ko) 2009-09-11
CY1110658T1 (el) 2015-06-10
AU2007327934B2 (en) 2013-04-18
EP2101792A2 (en) 2009-09-23
CN101678040A (zh) 2010-03-24
MA31145B1 (fr) 2010-02-01
PL2101792T3 (pl) 2010-11-30
AU2007327934A1 (en) 2008-06-12
HK1141980A1 (en) 2010-11-26
EA015930B1 (ru) 2011-12-30
CA2671317C (en) 2015-03-17
PT2101792E (pt) 2010-06-25
WO2008067982A3 (en) 2009-04-16
BRPI0720054A2 (pt) 2013-12-17
DE602007005697D1 (de) 2010-05-12
EP2101792B1 (en) 2010-03-31
JP5470047B2 (ja) 2014-04-16
DK2101792T3 (da) 2010-07-26
KR101437708B1 (ko) 2014-09-03

Similar Documents

Publication Publication Date Title
TN2009000211A1 (en) Antiviral composition and method of use
MX2010007936A (es) Anticuerpo anti-nr-10 y su uso.
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
EP2099449A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DISEASES THAT COME WITH IMPOTENCE
CL2007002261A1 (es) Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer.
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
TNSN08400A1 (en) Organic compounds and their uses
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
IL202351A (en) (2 – oxo – 1,3 – oxazolidine – 5 – ile)
TNSN08496A1 (en) Aminothiazoles and their uses
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
MX2009003301A (es) Novedoso inmunogeno neutralizante (nimiv) de rhinovirus y su uso para aplicaciones de vacunas.
UA94781C2 (ru) Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
JO2730B1 (en) Medications for the treatment of endometriosis
UA95630C2 (ru) Лизобактинамиды, способ их получения (варианты) и применение их как антибактериального средства
ATE380188T1 (de) Substituierte chinolone
UA88655C2 (ru) S-миртазапин для лечения прилива крови
WO2006089664A3 (de) Heterocyclylamid-substituierte imidazole
WO2008157365A3 (en) Vinylazacycloalkanes for treating neuropathic pain
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
MY166063A (en) Intravenous antiviral treatments
PL1837029T3 (pl) Kompozycja farmaceutyczna do zapobiegania i leczenia przeziębień
MX2009004237A (es) Uso de timosina alfa 1 para la preparacion de un medicamento para la prevencion y tratamiento de alergias.

Legal Events

Date Code Title Description
FG Grant or registration